Pharmaceutical, Biological and Chemical Patents

Germany is one of the world’s leading jurisdictions for patent litigation. In Europe alone, approx. 60 % of patent disputes are heard before courts in Germany. Answers to key questions in patent law and the possible interpretation thereof may be found in the rich array of case law from German courts. Pharmaceutical, biological and chemical patents are key matters in patent law. The fields present multiple challenges and source of legal disputes, especially in relation to matters of ‘state of the art’ and the different identifications of a substance and the resulting patents. German courts have given valuable insights to resolving globally significant issues. This handbook therefore focuses especially on German jurisprudence to identify key principles and trends, thereby providing valuable assistance and arguments in other jurisdictions.

Marco Stief is an internationally experienced patent law attorney. Maximilian Haedicke is professor of IP law at the University of Freiburg and a legally qualified judge at the Paris Central Division of the Unified Patent Court. Annelie Wünsche is a patent attorney.

For specialist patent law practitioners and judges, in-house counsels at global and domestic companies.